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Abstract
Distinguishing progressive mild cognitive impairment (pMCI) from stable mild cognitive 
impairment (sMCI) is critical for identification of patients who are at-risk for Alzheimer’s disease 
(AD), so that early treatment can be administered. In this paper, we propose a pMCI/sMCI 
classification framework that harnesses information available in longitudinal magnetic resonance 
imaging (MRI) data, which could be incomplete, to improve diagnostic accuracy. Volumetric 
features were first extracted from the baseline MRI scan and subsequent scans acquired after 6, 12, 
and 18 months. Dynamic features were then obtained by using the 18th-month scan as the 
reference and computing the ratios of feature differences for the earlier scans. Features that are 
linearly or non-linearly correlated with diagnostic labels are then selected using two elastic net 
sparse learning algorithms. Missing feature values due to the incomplete longitudinal data are 
imputed using a low-rank matrix completion method. Finally, based on the completed feature 
matrix, we build a multi-kernel support vector machine (mkSVM) to predict the diagnostic label of 
samples with unknown diagnostic statuses. Our evaluation indicates that a diagnosis accuracy as 
high as 78.2% can be achieved when information from the longitudinal scans is used – 6.6% 
higher than the case using only the reference time point image. In other words, information 
provided by the longitudinal history of the disease improves diagnosis accuracy.
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1. Introduction
Mild cognitive impairment (MCI) is a brain disorder characterized by noticeable impairment 
of cognitive functions, such as memory loss, beyond the decline due to normal aging, but not 
to the extent of significantly affecting activities of daily life. MCI is caused by 
neurodegeneration (loss or death of brain neuron cell), and is generally known as a 
transitional stage between normal aging and Alzheimer’s disease (AD). Studies suggest that 
3% to 19% of adults older than 65 years may be affected by MCI (Gauthier et al., 2006). 
Although some MCI patients recover over time, more than half will progress to dementia 
within 5 years (Gauthier et al., 2006). To identify patients who need to receive early 
treatment, it is vital to distinguish between progressive MCI (pMCI) patients, who will 
eventually progress to AD, from stable MCI (sMCI) patients, whose conditions will cease to 
deteriorate.
In the past few decades, a lot of studies have been focused on identifying possible 
biomarkers for AD/MCI diagnosis using neuroimaging data acquired with magnetic 
resonance imaging (MRI) (Weiner et al., 2013). MRI is a noninvasive technology that can be 
used to quantify gray and white matter integrity of the brain with high reproducibility 
(Haacke et al., 1999; Jack et al., 2008). MRI-based studies indicate that AD/MCI subjects 
are normally associated with cortical thinning and brain atrophy in the temporal lobe, 
parietal lobe, frontal cortex, and other brain regions (Jack et al., 2002; Stefan J et al., 2006; 
Whitwell et al., 2008). Based on these findings, different types of MRI-based measures, e.g., 
region-of-interest (ROI) based volumetric measures (Jack et al., 1999; Zhou et al., 2011; Li 
et al., 2015), cortical thickness measures (Querbes et al., 2009; Wee et al., 2013), 
morphometric measures (Ashburner and Friston, 2000; Hua et al., 2008), functional 
measures Wee et al. (2012a, 2014); ?); ?, and diffusion measures Wee et al. (2011, 2012b) 
have been proposed for AD/MCI diagnosis. In addition to MRI, other modalities such as 
positron emission topography (PET), cerebrospinal fluid (CSF), and genetic data have also 
been used (Kohannim et al., 2010; Hinrichs et al., 2009; Huang et al., 2011; Wang et al., 
2012; Zhang and Shen, 2012a). Compared with other modalities, structural MRI offers 
important advantages such as non-invasiveness, rapid acquisition, lower acquisition cost, and 
greater data availability. In this study, we focus our analysis on MRI data, even though our 
framework can be generalized and extended to include other modalities.
There are two broad categories of AD studies: cross-sectional and longitudinal. In cross-
sectional studies, only data from one time point are involved. Most studies using the 
Alzheimer’s Disease Neuroimaging Initiative (ADNI)1 dataset employ only the baseline 
data (i.e., the first screening data) and therefore belong to this category (Davatzikos et al., 
2011; Hinrichs et al., 2011; Weiner et al., 2013). The preference for cross-sectional studies is 
partly due to the completeness of the baseline data, both in terms of the number of subjects 
in different cohorts (i.e., AD, MCI and NC) and the number of modalities (i.e., MRI, PET 
and CSF) when compared with the data collected at subsequent time points. Due to greater 
data availability in the baseline, cross-sectional studies using the baseline data might benefit 
from greater statistical power. Moreover, complementary data from multiple modalities, 
1http://www.adni-info.org/
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which are most complete at the baseline, can be employed for more accurate AD/MCI 
analysis (Wang et al., 2012; Zhang and Shen, 2012a; Thung et al., 2014; Liu et al., 2014; ?; 
Huang et al., 2015; Zhu et al., 2015; Thung et al., 2015; Adeli-Mosabbeb et al., 2015). 
However, cross-sectional studies can only provide information on a single biological and 
neuropsychological state of the disease and is hence insufficient for characterizing the 
temporal evolution of the disease.
In longitudinal studies, data collected at multiple time points are involved (Zhang and Shen, 
2012b; Liu et al., 2013; Weiner et al., 2013). In contrast to data from a single time point, 
longitudinal data capture temporal dynamics, such as the rate of deterioration, of disease 
progression. For example, we can quantify pathological changes using MRI-based 
measurements from multiple time points to determine whether an MCI patient is progressing 
toward AD. However, due to various practical issues (e.g., subject drop-outs, image quality 
issues, etc.), longitudinal data are quite often incomplete. The easiest way to deal with this 
problem, as done in most studies, is by discarding samples with missing data (Liu et al., 
2013; Weiner et al., 2013) and performing analysis only using data that are complete. By 
doing so, sample size is inevitably reduced and hence statistical power is sacrificed (van der 
Heijden et al., 2006; MacCallum et al., 1996). An alternative to dealing with missing data is 
to perform data imputation, using methods such as k-nearest neighbor (KNN) (Speed, 2003; 
Troyanskaya et al., 2001), expectation maximization (EM) (Schneider, 2001), and low rank 
matrix completion (Candès and Recht, 2009; Goldberg et al., 2010; Sanroma et al., 2014).
In this study, we utilize longitudinal MRI data, with explicit consideration of missing data, 
for pMCI/sMCI classification. We hypothesize that pMCI patients undergo a trajectory of 
brain structural changes that is different from sMCI patients. This trajectory, which is 
reflected by the longitudinal MRI data, can be used to improve pMCI/sMCI classification. 
Our main contributions and findings are as follows:
1. We developed a pMCI identification framework using longitudinal 
incomplete data. Unlike longitudinal studies that discard incomplete data, 
we impute missing feature values and diagnostic labels of a testing sample 
simultaneously by utilizing all available samples.
2. We developed a feature selection method for incomplete longitudinal data, 
extracting, at each time point, features that are correlated linearly and 
nonlinearly with the class labels.
3. We found that dense temporal sampling is not always necessary for 
improving pMCI identification. Our investigation shows that scans that are 
appropriately spaced out in time is often sufficient.
Our framework uses both static and dynamic features to predict the diagnostic label of a 
sample. The static features are the gray matter volumes of 93 ROIs extracted from each MR 
image in the longitudinal series. The dynamic features are the volumetric change ratios 
computed between the image at a reference time point and images at other time points. By 
concatenating the static and dynamic features, each sample can be represented as a feature 
vector. All the feature vectors are stacked to form a feature matrix. Instead of performing 
imputation based on the whole matrix, we apply feature selection to reduce the matrix to 
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contain only discriminative features so that imputation can be carried out more effectively. 
More specifically, features that show linear and nonlinear relationships with clinical 
diagnostic labels are selected via least-squares and logistic elastic net regressions (Liu et al., 
2009). Missing feature values in the reduced feature matrix are then imputed using a label 
guided low rank matrix completion method (Goldberg et al., 2010). Lastly, we will build a 
classifier by using multiple kernel SVM (Rakotomamonjy et al., 2008), which combines a 
set of linear, Gaussian, and polynomial kernels. Experimental results show that our 
framework improves identification accuracy when longitudinal MRI data with dynamic 
features are used.
2. Materials and Data Processing
2.1. ADNI Background
Data used in the preparation of this article were obtained from the ADNI database 
(adni.loni.ucla.edu). The ADNI was launched in 2003 by the National Institute on Aging 
(NIA), the National Institute of Biomedical Imaging and Bioengineering (NIBIB), the Food 
and Drug Administration (FDA), private pharmaceutical companies and non-profit 
organizations, as a $60 million, 5-year public-private partnership. The primary goal of ADNI 
has been to test whether serial MRI, PET, other biological markers, and clinical and 
neuropsychological assessment can be combined to measure the progression of MCI and 
early AD. Determination of sensitive and specific markers of very early AD progression is 
intended to aid researchers and clinicians to develop new treatments and monitor their 
effectiveness, as well as lessen the time and cost of clinical trials.
The Principal Investigator of this initiative is Michael W. Weiner, MD, VA Medical Center 
and University of California - San Francisco. ADNI is the result of efforts of many co-
investigators from a broad range of academic institutions and private corporations, and 
subjects have been recruited from over 50 sites across the U.S. and Canada. The initial goal 
of ADNI was to recruit 800 subjects but ADNI has been followed by ADNI-GO and 
ADNI-2. To date, these three protocols have recruited over 1500 adults, ages 55 to 90, to 
participate in the research, consisting of cognitively normal older individuals, people with 
early or late MCI, and people with early AD. The follow up duration of each group is 
specified in the protocols for ADNI-1, ADNI-2 and ADNI-GO. Subjects originally recruited 
for ADNI-1 and ADNI-GO had the option to be followed in ADNI-2. For up-to-date 
information, see www.adni-info.org.
2.2. Materials
In the ADNI dataset, there are about 400 MCI subjects scanned at screening time (i.e., the 
baseline). After the baseline scan, follow-up scans were acquired every 6 or 12 months for 
up to 84 months. MCI subjects who progressed to AD after some period of time were 
retrospectively labelled as pMCI subjects. Following this convention, the labelling of pMCI/
sMCI is affected by the reference time point and the time period in which the patients are 
monitored for conversion to AD. We chose the 18th month as the reference and 30 months 
as the time period to monitor for conversion, so that there is a sufficient number of earlier 
scans (i.e., baseline, 6th, and 12th month) in each cohort (i.e., pMCI and sMCI). Thus, 
Thung et al. Page 4
Brain Struct Funct. Author manuscript; available in PMC 2017 November 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
patients who converted to AD within the 18th to 48th month (a duration of 30 months) are 
labelled as pMCI patients, and those whose conditions do not deteriorate are labelled as 
sMCI patients. Patients who converted to AD prior to the 18th month were excluded from 
the study because they were no longer MCI patients at the reference time point. Patients who 
converted to AD after the 48th month were also excluded to avoid labelling uncertainty. 
Based on the criteria mentioned above, a total of 60 pMCI and 53 sMCI subjects were 
available for this study. The associated demographic information is shown in Table 1. Using 
the data at and before the 18th month, we investigated whether longitudinal MRI scans are 
conducive to improving pMCI/sMCI classification.
2.3. MR Image Processing
A maximum of 4 time points were used – baseline, 6th month, 12th month, and 18th month. 
The processing steps involved are described as follows. Each MRI T1-weighted image was 
first anterior commissure (AC) – posterior commissure (PC) corrected using MIPAV2, 
intensity inhomogeneity corrected using the N3 algorithm (Sled et al., 1998), skull stripped 
(Wang et al., 2011) with manual editing, and cerebellum-removed (Wang et al., 2014). We 
then used FAST (Zhang et al., 2001) in the FSL package3 to segment the image into gray 
matter (GM), white matter (WM), and cerebrospinal fluid (CSF), and used HAMMER (Shen 
and Davatzikos, 2002) to register the images to a common space. GM volumes obtained 
from 93 ROIs defined in (Kabani, 1998), normalized by the total intracranial volume, were 
extracted as features.
3. pMCI/sMCI Classification Framework
3.1. Image Features
Let {Tt ∈ ℝn×r, t = 1, …, 4} denote the matrices containing the r = 93 ROI volumetric 
features of n subject samples at baseline (t = 1), 6th month, 12th month, and 18th month (t = 
4), respectively. Additional dynamic features are computed as the volumetric change ratios 
between 18th month (reference time point) and earlier time points, i.e., {Dt = (Tt − T4) · /(T4 
+ c), t = 1, …, 3}, where ·/ denotes element-wise division, and c is a small constant to avoid 
division by zero. Since the ADNI longitudinal data were not acquired exactly at the design 
time points, we normalize the dynamic features using the following method. The normalizer 
for the j-th row (i.e., j-th subject) of Dt is denoted as
(1)
The corrected dynamic features is given by
2http://mipav.cit.nih.gov
3http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/
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(2)
where Wt = diag(wt,1, wt,2, ···, wt,j, ···, wt,n).
For simplicity, we concatenate all the volumetric and dynamic features into a matrix X = 
[X(1) ··· X(i) ··· X(m)] ∈ ℝn×d, where d = r × m is the total number of features for one subject 
sample, and m is the total number of feature submatrices. Depending on the number of time 
points and the feature combination used in the experiments, each feature submatrix X(i) 
represents either Tt or Dt. For example, if all volumetric and dynamic features from all 4 
time points are used, there are m = 7 submatrices: X(i) = T5–i for i = {1, 2, 3, 4}, X(i) = D8–i 
for i = {5, 6, 7}, and X = [X(1) ··· X(i) ··· X(m)] = [T4 T3 T2 T1 D3 D2 D1]. Denoting y ∈ 
ℝn×1 as the target label vector (1 for pMCI, −1 for sMCI), our objective is to predict Y given 
X.
3.2. Framework Overview
The proposed framework (see Figure 1) consists of three components: feature selection, data 
imputation using matrix completion, and classification using multi-kernel support vector 
machine (mkSVM). We partitioned the feature matrix into training and testing samples: 
. Our model was trained with Xtrn ∈ ℝntrn×d, and was tested with Xtst ∈ 
ℝntst×d. The corresponding target label vectors for the training and testing data are denoted 
as Ytrn ∈ ℝntrn×1 and Ytst ∈ ℝntst×1, respectively. Since some feature values are possibly 
missing in X due to the incomplete dataset, data imputation is needed before it can be used 
to train a classifier. To reduce the number of values that need to be imputed and also to 
restrict imputation to only discriminative features, we first reduce the size of Xtrn via feature 
selection.
3.3. Feature Selection
Sparse feature selection methods such as least absolute shrinkage and selection operator 
(Lasso) (Tibshirani, 1996) and its variants (Zou and Hastie, 2005; Friedman et al., 2010; 
Simon et al., 2013; Zhou et al., 2012; Zhang et al., 2012) have been shown to be effective in 
dealing with high-dimensional data. However, these feature selection methods can only be 
applied to complete data with no missing values. One workaround for this problem is to 
apply feature selection on complete subset(s) of the data. Three methods can be used to 
extract such subsets, as shown in Figure 2. Each feature submatrix in the figure represents 
data from one time point (volumetric or dynamic features), and each color box in the figure 
represents the subset of data. For simplicity, we use an example of incomplete data with only 
three feature submatrices. The first method (Figure 2(a)), which is widely used, discards 
samples with missing values and retains only complete samples, thus throwing away a 
significant amount of useful information. The second and third methods (Figure 2(b) and 
(c)) avoid this problem by using multiple complete subsets. Specifically, the second method 
defines subsets according to feature submatrices, while the third method defines subsets 
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according to combinations of features. To maximize the number of samples for each subset, 
the third method allows overlaps among subsets. In this study, the second method was used.
In longitudinal data, the volumetric features vary gradually over time and are highly 
correlated. Based on our experience, if sparse method such as Lasso is used for feature 
selection on data from two or more time points, similar but not necessarily redundant 
features will be removed. We avoid this problem by performing elastic net feature selection 
for each submatrix , i.e., second method in Figure 2(b). In addition, we use two types of 
elastic net regressions, least-squares and logistic regressions both with elastic net regularizer 
(Liu et al., 2009), to select features that are linearly and non-linearly correlated with the 
target labels (see feature selection component in Figure 1). The problems associated with the 
two sparse regressions are given as
(3)
(4)
where  is the j-th samples in , yj is the corresponding j-th output label, ||·||1 is 
the l1-norm, ||·||2 is the l2-norm, and λ1 to λ4 are the regularization parameters. Elastic net 
enforces l1-norm and l2-norm penalization on the weight vector β(i) ∈ ℝr×1, combining the 
advantages of both Lasso and ridge regressions. In particular, the l1-norm in the above 
equations causes weight vectors and  to be sparse, while the l2-norm helps to retain 
highly correlated features. Features corresponding to the rows with non-zero values in 
matrix  were selected from { , i = 1, 2, …}. This implies that the 
same set of features will be selected for all feature submatrices in Xtrn. Features found 
discriminant at one time point will also be selected at other time points.
3.4. Matrix Completion
After feature selection, we obtain feature-reduced matrices Ztrn and Ztst, which are possibly 
incomplete due to missing data. While there are a number of existing data imputation 
methods (Schneider, 2001; Goldberg et al., 2010; Ma et al., 2011; Troyanskaya et al., 2001), 
we chose to use a label guided low rank matrix completion algorithm (Goldberg et al., 2010; 
Thung et al., 2014). This is because the longitudinal data are highly correlated and each 
column of  could potentially be represented by a linear combination of other 
columns in Z, satisfying the low rank assumption of low rank matrix completion algorithm. 
Following (Goldberg et al., 2010), we augmented Z with the target label vector before 
performing matrix completion. More specifically, matrix completion is performed on an 
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augmented matrix , where Ytst is unknown and will be imputed (Thung 
et al., 2014). The imputed or completed matrix is denoted as , where Ŷtrn 
is same as Ytrn as there is no missing label in the training set. The imputation optimization 
problem is given as:
(5)
where ΩZ and ΩY denote the set of indices of the observed non-missing values in Z and the 
label vector Y, respectively, |.| denotes the cardinality of a set, ||.||* denotes the trace norm, qij 
and q̂ij denote the original and the predicted values, respectively. The first term in the above 
equation is to ensure that the predicted matrix Q̂ is low rank. The second term is the squared 
loss term L1(u, v) = 1/2(u − v)2, which accounts for errors in feature imputation. The final 
term is a logistic loss term L2(u, v) = log(1+exp(−uv)), which accounts for errors in label 
imputation. λm and μ are the positive-valued tuning parameters. The imputed label vector 
Ytst can be taken as the predicted labels without explicitly building a classifier. To improve 
the prediction accuracy, we detail in the following how classifiers can be constructed based 
on the completed feature matrix.
3.5. Classification
Various classifiers can be constructed based on the completed feature matrix Ẑtrn to predict 
the class label vector Y. First, we applied least-squares elastic nets, logistic elastic net, linear 
kernel SVM, and Gaussian kernel SVM on Ẑtrn as a whole for prediction. Second, we used 
the kernel trick to combine different feature submatrices into a single matrix for prediction. 
Specifically, we built one or more kernels for each feature submatrix, and combined them 
into a single kernel by using either multiple kernel learning algorithms, such as multi kernel 
SVM (mkSVM) or averaging algorithms, such as mean multi-kernel SVM (mean-mkSVM).
3.5.1. Least-Square Sparse Regression Elastic Net (leastR)—We learn a sparse 
weight β that, when mapped by Z, best explains Ytrn. This is achieved by solving a l2-norm 
and l1-norm regularized least-squares problem. That is
(6)
The label vector Ytst is predicted based on Ẑtest and is given by Ẑtestβ.
3.5.2. Logistic Sparse Regression Elastic Net (logisticR)—This is similar to leastR 
classifier, but with the least-squares function replaced by the logistic loss function. That is
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(7)
The label vector Ytst is given by Ẑtestβ + c.
3.5.3. Support Vector Machine (SVM)—The dual formulation of SVM (Chang and Lin, 
2011) is given as
(8)
where  is a vector of dual variables, C is the 
regularization parameter, K(Ẑj, Ẑk) is the kernel that indicates the similarity between sample 
Ẑj ∈ ℝ1×nf and Ẑk ∈ ℝ1×nf in Ẑtrn, and nf is the number of features for each sample. We built 
linear kernel (Klinear (Ẑj, Ẑk) = 〈Ẑj, Ẑk〉) and Gaussian kernel 
( ) using Ẑtrn for the prediction of Ytst.
3.5.4. Multi-Kernel SVM (mkSVM)—Combining multiple kernels (Gönen and Alpaydin, 
2011) has been shown to improve classification performance. Thus, instead of using a single 
kernel, we combined multiple kernels using multi-kernel support vector machine (mkSVM). 
Specifically, we built multiple kernels (i.e., linear, Gaussian and polynomial kernels with 
different parameters) for each submatrix in Ẑtrn, and then used multiple kernel learning 
(MKL) to estimate the kernel combination weights.
The dual formulation of mkSVM (Rakotomamonjy et al., 2008) is given as
(9)
where  is a vector of dual variables,  is the kernel weight matrix, C is the 
regularization parameter, Q is the total number of kernels, and  is the q-th 
kernel between sample  and  in . We used three types of kernels: 
linear kernel Klinear(Ẑj, Ẑk) = 〈Ẑj, Ẑk〉, Gaussian kernel 
( , and polynomial kernel (Kpolynomial(Ẑj, Ẑk) = (〈Ẑj, 
Ẑk〉+1)p). We employed 5 values for s and 3 values for p. Thus, each submatrix in Ẑtrn 
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corresponds to a total of Q = 9 kernels, and for m submatrices, we have a total of 9m 
kernels. These kernels were combined by using the learned weight matrix η in 
. The equality constraint  in (9), which is 
similar to l1-norm, causes η to be sparse, and only the most discriminative kernels were 
selected. After obtaining α and η from the training data, the class label for a test sample Ẑtst 
was estimated by , where b is the bias term 
obtained from the support vectors. For more detail on mkSVM, please refer to (Gönen and 
Alpaydin, 2011).
3.5.5. Mean Multi-Kernel SVM (mean-mkSVM)—Mean-mkSVM is similar to 
mkSVM, but instead of learning the kernel weights, the kernels are combined by simple 
averaging and therefore all kernels are combined with equal weighting. Since nonlinear 
kernel is very sensitive to parameter selection, only the linear kernel is used for mean-
mkSVM, similar to (Zhang and Shen, 2012b).
4. Results and Discussions
4.1. Performance Measure
We used accuracy, sensitivity, and specificity to evaluate the performance of the proposed 
classification framework. In addition, the Receiver Operating Characteristic (ROC) curve 
was used to summarize the classifier performance over a range of tradeoffs between true 
positive and false positive error rates (Swets, 1988). The Area Under the ROC Curve (AUC) 
(Lee, 2000; Duda et al., 2012; Bradley, 1997), used as the fourth measure, is independent to 
the decision criterion used and is less sensitive to data imbalance. Thus, AUC is the most 
representative performance measure in this study. All the results reported in this paper are 
the average of 10 repetitions in 10-fold cross validation.
4.2. Parameter Selection
We evaluated our framework using different classifiers, including leastR, logisticR, linear-
kernel SVM (SVMlin), Gaussian-kernel SVM (SVMrbf), mkSVM, and mean-mkSVM. All 
the hyperparameters (e.g., λ, C, and s) used for the classifiers (and the feature selections) are 
determined through 5-fold cross validation, using only the training data. Also included are 
the classification results obtained using low rank label imputation technique (LRMC), as 
described in our previous work (Thung et al., 2014, 2013). The parameters λm and μ of 
LRMC are set at 0.1 and 10−5, respectively, based on our previous work (Thung et al., 
2014).
4.3. Feature Combinations
Three feature combinations were tested in this study (see Figure 3), i.e., FT – volumetric 
features only; FTD – volumetric and all the corresponding dynamic features; FT4D – 
volumetric features from the fourth (18 month) time point and all the corresponding 
dynamic features. The number of dynamic features used was determined by the number of 
time points used in the experimental study. For example, if time point 4 and time point 3 are 
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used, there is only 1 type of dynamic feature, i.e., D3; while if all the time point are used, 
there are 3 types of dynamic features, i.e., D3, D2 and D1. In the following subsections, we 
report the results for our framework using different combinations of time points, 
combinations of features, feature selection methods, and classifiers.
4.4. Evaluation – Effect of Increasing the Number of Time Points
Figures 4 and 5 show the effect of the number of time points on accuracy and AUC using 
different combinations of features. The first row of both figures indicates that, without 
dynamic features (i.e., FT), there is no significance difference in performance even using 
data from more than one time point. In contrary, feature combinations that utilize dynamic 
features, i.e., FTD and FT4D, perform significantly better. With dynamic features, there is a 
trend of increasing performance (both in term of accuracy and AUC) when using data from 
more earlier time points. The plots in Figure 4 and Figure 5 also indicate that the 
performance of the framework is not always improved when using data from more than one 
time point. For example, when compared with time point 4 (reference or “latest” time point), 
the performance of the proposed classifier (i.e., mkSVM) drops slightly when including 
additional data from time point 3, but increases afterward when using additional data from 
time points 2 and 1. Similar trend is observed using other classifiers (e.g., leastR, SVMlin, 
LRMC, mean-mkSVM), but with a much significant drop in performance using the dynamic 
features from time points 4 and 3. This is potentially due to the relatively smaller time 
separation between time points 4 and 3 (only 6 months apart). The images are hence 
relatively similar and do not offer much additional information, and also the dynamic 
features could be noisy. Nevertheless, unlike other classifiers, the proposed mkSVM, which 
assigns different weights to the kernels derived from different data, can avoid this issue 
effectively.
4.5. Evaluation – Effect of Scan Time Interval
We investigate here the effect of scan time interval between two MRI scans on classification 
accuracy. Figure 6 and Figure 7 show the results of pMCI identification using data from the 
reference time point and one additional earlier time point. From the figure, it can be seen 
that when the scanning time interval of the 2 time points increases, so does the classification 
accuracy and the AUC. This trend is seen for all the three feature combinations and for 
almost all the classifiers. The reason behind this observation could be that the brain 
structures of the subjects change more significantly when scan time interval is increased, 
making the dynamic features more useful. pMCI subjects encounters a greater rate of 
neurodegeneration than sMCI subjects. The dynamic features capture this difference from 
the longitudinal data and improve pMCI/sMCI classification accuracy. We also note that the 
improvement gained by using 2 time points is comparable to that using more time points. 
This observation indicates that the time interval between scans is a more important factor in 
pMCI identification than the number of scans.
4.6. Evaluation – Effect of Feature Combination
When comparing the performance difference among FT, FTD, and FT4D, we found that FTD, 
and FT4D, which utilize dynamic features, are significantly better than FT, which uses only 
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MRI ROI-based features. This observation can be seen in Figures 4 to 7. For example, 
considering all time points, the best AUC values are 0.783, 0.823, and 0.829, for FT, FTD, 
and FT4D, respectively. If considering only the first and fourth time points, the best AUCs 
achieved by FT, FTD, and FT4D are 0.793, 0.843, and 0.833, respectively. In other words, 
using FTD and FT4D gives an increase of accuracy of about 4–5 % over FT, when using time 
points 1 and 4, achieved by our proposed classifier (mkSVM).
4.7. Evaluation – Effect of Classifier
The performance of the classifiers depends on the feature combination used. For FT, the 
performances of SVMlin, SVMrbf, LRMC, mean-mkSVM, and mkSVM are comparable, 
while the performances of leastR and logisticR are relatively inferior. For FTD and FT4D, 
mkSVM in overall performs better than other classifiers for all combinations of time points. 
For FTD, the highest AUC value (0.843) is achieved by mkSVM, using data from time points 
1 and 4. This is 6.6% higher than its AUC when using only time point 4. Similar conclusions 
can also be drawn when using FT4D. The complete results in terms of accuracy, sensitivity, 
specificity and AUC are shown in Tables 2 to 5. In term of sensitivity, mkSVM always 
performs the best for all these feature combinations.
4.8. Evaluation – Effect of Feature Selection Methods
We compared the performance when either Eq.(3) (igLeastR) or Eq.(4) (igLogisticR) is 
applied independently. Student’s t-test was also applied for feature selection by removing 
features that are not statistically significantly correlated with the class label (igt-test). We 
also compared our method with least-squares (glLeastR) and logistic (glLogisticR) group 
Lasso regressions (Liu et al., 2009). Specifically, regression is performed using the 
submatrix of complete data extracted from the full feature matrix (Figure 2(a)), and the 
weight matrix is penalized via l2,1-norm. Weights corresponding to features of the same ROI 
from different feature submatrices are grouped using the l2-norm and the different groups 
are associated using the l1-norm. Table 6 shows the average AUC of the proposed mkSVM 
(over 10 repetitions of 10-fold cross validation) using different feature selection methods and 
feature combinations (i.e., FT, FTD, and FT4D). The results show that our proposed feature 
selection method, in most cases, outperforms all other methods in terms of AUC. All feature 
selection methods, except igt-test, always show better AUC values, when using data FTD and 
FTD from all time points or from two well-separated time points (e.g., T4,1). The relatively 
lower performance of group Lasso is probably because 1) group Lasso tends to select ROIs 
that are discriminant for all time points, which possibly removes discriminant features that 
only appeared at certain time points, 2) only samples with a complete feature set are used in 
feature selection. In contrast, the proposed method avoids the weaknesses above by using 
elastic net regression on each feature submatrix. The superior performance of the proposed 
method over leastR and logisticR methods also shows the advantage of combining features 
selected by two elastic net regressions within each feature submatrix while at the same time 
requiring common feature sets across feature submatrices.
4.9. Frequency Map of Selected Features
Figures 8 and 9 shows the frequency map of selected features using the proposed feature 
selection method, for FT and FT4D, respectively. The left and right maps of the figure show 
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the feature selection frequency maps for ROIs from the left hemisphere and right hemisphere 
of the brain, respectively. Each row of the map denotes feature from one ROI, with its name 
shown between the two maps. There are 47 rows in each map, corresponding to 46 ROIs for 
each hemisphere and 1 ROI for the corpus callosum. Each column denotes a combination of 
time points. Comparing Figures 8 and 9, more ROIs are selected due to the existence of 
dynamic features. Some frequently selected ROIs include precuneus, hippocampal 
formation, perrihinal cortex, entorhinal cortex, amygala, middle temporal gyrus, inferior 
temporal gyrus, and lateral occipitotemporal gyrus. These regions are involved in memory 
formation, processing and storing (Burgess et al., 2002; Stanislav et al., 2013; Smith and 
Kosslyn, 2006; Poulin et al., 2011; Ranganath, 2006; Yonelinas et al., 2001). The corpus 
callosum, which is associated with AD and MCI (Di Paola et al., 2010; Wang et al., 2006), is 
also frequently selected.
4.10. Probability Density Function of Dynamic Features
We have suggested previously that the improvement of pMCI identification using 
longitudinal data with longer scan time interval (Figure 6 and Figure 7) is due to the larger 
volumetric differences and hence more significant dynamic features. To evaluate the validity 
of this observation, we used 31 most frequently selected ROIs (Figure 9) and plot the 
distribution of the corresponding volumetric differences (i.e., {Ti – T4}) in Figure 10. The 
results indicate that the distribution of T1 – T4 is the broadest, followed by T2 – T4 and T3 – 
T4. This observation is consistent with our assumption that D1, which represents the 
dynamic features obtained from MRI data with relatively larger scan interval, is able to 
capture the variability between pMCI and sMCI subjects.
5. Conclusion
We have proposed a pMCI/sMCI classification framework that harnesses the additional 
information given by possibly incomplete longitudinal data. The experimental results 
demonstrate that classification performance improves when data from multiple time points 
with sufficient separation in scanning times are used. We also observed that, rather than 
using only static volumetric features, dynamic features can be used to improve classification 
performance. Feature selection using combined elastic net regressions has been shown to be 
more effective than feature selection using these regression techniques independently. The 
proposed classifier (mkSVM) outperforms other state-of-the-art classifiers when dynamic 
features are used. The best classification accuracy using two time points was achieved by 
mkSVM at 78.2%, which is 6.6% more than the accuracy it achieved by using only the 
reference time point. Similarly, the best AUC using two time points was achieved by 
mkSVM at 84.3%, which is 6.6% more than the AUC it achieved by using only the 
reference time point. In the future, we will extend the current framework to work with 
multiple imaging modalities (e.g., PET and CSF) and multiple clinical scores (e.g., MMSE 
(Wechsler, 1945) and ADAS (Doraiswamy et al., 1997)) to further improve classification 
performance.
Acknowledgments
This work was supported in part by NIH grants AG041721, AG042599, EB006733, EB008374, and EB009634.
Thung et al. Page 13
Brain Struct Funct. Author manuscript; available in PMC 2017 November 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Data collection and sharing for this project was funded by the Alzheimer’s Disease Neuroimaging Initiative (ADNI) 
National Institutes of Health Grant U01 AG024904. ADNI is funded by the National Institute on Aging, the 
National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the 
following: Abbott, AstraZeneca AB, Amorfix, Bayer Schering Pharma AG, Bioclinica Inc., Biogen Idec, Bristol-
Myers Squibb, Eisai Global Clinical Development, Elan Corporation, Genentech, GE Healthcare, Innogenetics, 
IXICO, Janssen Alzheimer Immunotherapy, Johnson and Johnson, Eli Lilly and Co., Medpace, Inc., Merck and 
Co., Inc., Meso Scale Diagnostic, & LLC, Novartis AG, Pfizer Inc, F. Hoffman-La Roche, Servier, Synarc, Inc., and 
Takeda Pharmaceuticals, as well as non-profit partners the Alzheimer’s Association and Alzheimer’s Drug 
Discovery Foundation, with participation from the U.S. Food and Drug Administration. Private sector contributions 
to ADNI are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee 
organization is the Northern California Institute for Research and Education, and the study is coordinated by the 
Alzheimer’s Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by 
the Laboratory for Neuro Imaging at the University of California, Los Angeles. This research was also supported by 
NIH grants P30 AG010129, K01 AG030514, and the Dana Foundation.
References
Adeli-Mosabbeb E, Thung KH, An L, Shi F, Shen D. Robust feature-sample linear discriminant 
analysis for brain disorders diagnosis. Neural Information Processing Systems (NIPS). 2015
Ashburner J, Friston KJ. Voxel-based morphometrythe methods. Neuroimage. 2000; 11:805–821. 
[PubMed: 10860804] 
Bradley AP. The use of the area under the ROC curve in the evaluation of machine learning algorithms. 
Pattern recognition. 1997; 30:1145–1159.
Burgess N, Maguire EA, O’Keefe J. The human hippocampus and spatial and episodic memory. 
Neuron. 2002; 35:625–641. [PubMed: 12194864] 
Candès EJ, Recht B. Exact matrix completion via convex optimization. Foundations of Computational 
Mathematics. 2009; 9:717–772.
Chang CC, Lin CJ. LIBSVM: a library for support vector machines. ACM Transactions on Intelligent 
Systems and Technology (TIST). 2011; 2:27.
Davatzikos C, Bhatt P, Shaw LM, Batmanghelich KN, Trojanowski JQ. Prediction of MCI to AD 
conversion, via MRI, CSF biomarkers, and pattern classification. Neurobiology of aging. 2011; 
32:2322–e19. [PubMed: 20594615] 
Di Paola M, Di Iulio F, Cherubini A, Blundo C, Casini A, Sancesario G, Passafiume D, Caltagirone C, 
Spalletta G. When, where, and how the corpus callosum changes in MCI and AD- a multimodal 
MRI study. Neurology. 2010; 74:1136–1142. [PubMed: 20368633] 
Doraiswamy P, Bieber F, Kaiser L, Krishnan K, Reuning-Scherer J, Gulanski B. The Alzheimer’s 
disease assessment scale patterns and predictors of baseline cognitive performance in multicenter 
Alzheimer’s disease trials. Neurology. 1997; 48:1511–1517. [PubMed: 9191757] 
Duda, RO.; Hart, PE.; Stork, DG. Pattern classification. John Wiley & Sons; 2012. 
Friedman J, Hastie T, Tibshirani R. A note on the group lasso and a sparse group lasso. 2010 arXiv 
preprint arXiv:1001.0736. 
Gauthier S, Reisberg B, Zaudig M, Petersen RC, Ritchie K, Broich K, Belleville S, Brodaty H, Bennett 
D, Chertkow H, et al. Mild cognitive impairment. The Lancet. 2006; 367:1262–1270.
Goldberg A, Zhu X, Recht B, Xu J, Nowak R. Transduction with matrix completion: three birds with 
one stone. Advances in Neural Information Processing Systems. 2010; 23:757–765.
Gönen M, Alpaydin E. Multiple kernel learning algorithms. The Journal of Machine Learning 
Research. 2011; 12:2211–2268.
Haacke, EM.; Brown, RW.; Thompson, MR.; Venkatesan, R. Magnetic resonance imaging. Wiley-Liss; 
New York: 1999. 
van der Heijden GJ, Donders TAR, Stijnen T, Moons KG. Imputation of missing values is superior to 
complete case analysis and the missing-indicator method in multivariable diagnostic research: a 
clinical example. Journal of clinical epidemiology. 2006; 59:1102–1109. [PubMed: 16980151] 
Hinrichs, C.; Singh, V.; Xu, G.; Johnson, S. MKL for robust multimodality AD classification, in: 
Medical Image Computing and Computer-Assisted Intervention–MICCAI 2009. Springer; 2009. p. 
786-794.
Thung et al. Page 14
Brain Struct Funct. Author manuscript; available in PMC 2017 November 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Hinrichs C, Singh V, Xu G, Johnson SC. Predictive markers for AD in a multi-modality framework: an 
analysis of MCI progression in the ADNI population. Neuroimage. 2011; 55:574–589. [PubMed: 
21146621] 
Hua X, Leow AD, Parikshak N, Lee S, Chiang MC, Toga AW, Jack CR Jr, Weiner MW, Thompson 
PM. Tensor-based morphometry as a neuroimaging biomarker for Alzheimer’s disease: an MRI 
study of 676 AD, MCI, and normal subjects. Neuroimage. 2008; 43:458–469. [PubMed: 
18691658] 
Huang, L.; Gao, Y.; Jin, Y.; Thung, KH.; Shen, D. Machine Learning in Medical Imaging. Springer; 
2015. Soft-split sparse regression based random forest for predicting future clinical scores of 
Alzheimers disease; p. 246-254.
Huang S, Li J, Ye J, Wu T, Chen K, Fleisher A, Reiman E. Identifying Alzheimer’s disease-related 
brain regions from multi-modality neuroimaging data using sparse composite linear discrimination 
analysis. Advances in Neural Information Processing Systems. 2011:1431–1439.
Jack C, Dickson D, Parisi J, Xu Y, Cha R, Obrien P, Edland S, Smith G, Boeve B, Tangalos E, et al. 
Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and 
dementia. Neurology. 2002; 58:750–757. [PubMed: 11889239] 
Jack C, Petersen R, Xu Y, OBrien P, Smith G, Ivnik R, Boeve B, Waring S, Tangalos E, Kokmen E. 
Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology. 
1999; 52:1397–1397. [PubMed: 10227624] 
Jack CR, Bernstein MA, Fox NC, Thompson P, Alexander G, Harvey D, Borowski B, Britson PJ, 
Whitwell LJ, Ward C, et al. The Alzheimer’s disease neuroimaging initiative (ADNI): MRI 
methods. Journal of Magnetic Resonance Imaging. 2008; 27:685–691. [PubMed: 18302232] 
Kabani NJ. A 3D atlas of the human brain. Neuroimage. 1998; 7:S717.
Kohannim O, Hua X, Hibar DP, Lee S, Chou YY, Toga AW, Jack CR, Weiner MW, Thompson PM. 
Boosting power for clinical trials using classifiers based on multiple biomarkers. Neurobiology of 
aging. 2010; 31:1429–1442. [PubMed: 20541286] 
Lee SS. Noisy replication in skewed binary classification. Computational statistics & data analysis. 
2000; 34:165–191.
Li F, Tran L, Thung KH, Ji S, Shen D, Li J. A robust deep model for improved classification of 
AD/MCI patients. Biomedical and Health Informatics. 2015
Liu F, Wee CY, Chen H, Shen D. Inter-modality relationship constrained multi-modality multi-task 
feature selection for alzheimer’s disease and mild cognitive impairment identification. Neuro 
Image. 2014; 84:466–475. [PubMed: 24045077] 
Liu, J.; Ji, S.; Ye, J. SLEP: Sparse Learning with Efficient Projections. Arizona State University; 2009. 
Liu, M.; Suk, HI.; Shen, D. Multi-task sparse classifier for diagnosis of MCI conversion to AD with 
longitudinal MR images. In: Wu, G.; Zhang, D.; Shen, D.; Yan, P.; Suzuki, K.; Wang, F., editors. 
Machine Learning in Medical Imaging. Springer International Publishing. volume 8184 of Lecture 
Notes in Computer Science. 2013. p. 243-250.
Ma S, Goldfarb D, Chen L. Fixed point and Bregman iterative methods for matrix rank minimization. 
Mathematical Programming. 2011; 128:321–353.
MacCallum RC, Browne MW, Sugawara HM. Power analysis and determination of sample size for 
covariance structure modeling. Psychological methods. 1996; 1:130.
Poulin SP, Dautoff R, Morris JC, Barrett LF, Dickerson BC. Amygdala atrophy is prominent in early 
Alzheimer’s disease and relates to symptom severity. Psychiatry Research: Neuroimaging. 2011; 
194:7–13. [PubMed: 21920712] 
Querbes O, Aubry F, Pariente J, Lotterie JA, Démonet JF, Duret V, Puel M, Berry I, Fort JC, Celsis P, 
et al. Early diagnosis of Alzheimer’s disease using cortical thickness: impact of cognitive reserve. 
Brain. 2009; 132:2036–2047. [PubMed: 19439419] 
Rakotomamonjy A, Bach FR, Canu S, Grandvalet Y. SimpleMKL. Journal of Machine Learning 
Research. 2008; 9
Ranganath C. Working memory for visual objects: complementary roles of inferior temporal, medial 
temporal, and prefrontal cortex. Neuroscience. 2006; 139:277–289. [PubMed: 16343785] 
Sanroma, G.; Wu, G.; Thung, K.; Guo, Y.; Shen, D. Machine Learning in Medical Imaging. Springer; 
2014. Novel multi-atlas segmentation by matrix completion; p. 207-214.
Thung et al. Page 15
Brain Struct Funct. Author manuscript; available in PMC 2017 November 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Schneider T. Analysis of incomplete climate data: Estimation of mean values and covariance matrices 
and imputation of missing values. Journal of Climate. 2001; 14:853–871.
Shen D, Davatzikos C. HAMMER: hierarchical attribute matching mechanism for elastic registration. 
IEEE Transactions on Medical Imaging. 2002; 21:1421–1439. [PubMed: 12575879] 
Simon N, Friedman J, Hastie T, Tibshirani R. A sparse-group lasso. Journal of Computational and 
Graphical Statistics. 2013; 22:231–245.
Sled JG, Zijdenbos AP, Evans AC. A nonparametric method for automatic correction of intensity 
nonuniformity in MRI data. IEEE Transactions on Medical Imaging. 1998; 17:87–97. [PubMed: 
9617910] 
Smith, EE.; Kosslyn, SM. Cognitive psychology: Mind and brain. Pearson Prentice Hall; 2006. 
Speed, T. Statistical analysis of gene expression microarray data. CRC Press; 2003. 
Stanislav K, Alexander V, Maria P, Evgenia N, Boris V. Anatomical characteristics of cingulate cortex 
and neuropsychological memory tests performance. Procedia-Social and Behavioral Sciences. 
2013; 86:128–133.
Stefan JT, Pruessner JC, Faltraco F, Born C, Rocha-Unold M, Evans A, Möller HJ, Hampel H. 
Comprehensive dissection of the medial temporal lobe in ad: measurement of hippocampus, 
amygdala, entorhinal, perirhinal and parahippocampal cortices using MRI. Journal of neurology. 
2006; 253:794–800. [PubMed: 16511646] 
Swets JA. Measuring the accuracy of diagnostic systems. Science. 1988; 240:1285–1293. [PubMed: 
3287615] 
Thung, KH.; Wee, CY.; Yap, PT.; Shen, D. Machine Learning in Medical Imaging. Springer; 2013. 
Identification of Alzheimers Disease using incomplete multimodal dataset via matrix shrinkage 
and completion; p. 163-170.
Thung KH, Wee CY, Yap PT, Shen D. Neurodegenerative disease diagnosis using incomplete multi-
modality data via matrix shrinkage and completion. Neuroimage. 2014; 91:386–400. [PubMed: 
24480301] 
Thung, KH.; Yap, PT.; Adeli-M, E.; Shen, D. Medical Image Computing and Computer-Assisted 
InterventionMICCAI 2015. Springer; 2015. Joint diagnosis and conversion time prediction of 
progressive mild cognitive impairment (pmci) using low-rank subspace clustering and matrix 
completion; p. 527-534.
Tibshirani R. Regression shrinkage and selection via the lasso. Journal of the Royal Statistical Society. 
Series B (Methodological). 1996:267–288.
Troyanskaya O, Cantor M, Sherlock G, Brown P, Hastie T, Tibshirani R, Botstein D, Altman RB. 
Missing value estimation methods for DNA microarrays. Bioinformatics. 2001; 17:520–525. 
[PubMed: 11395428] 
Wang H, Nie F, Huang H, Risacher SL, Saykin AJ, Shen L, et al. Identifying disease sensitive and 
quantitative trait-relevant biomarkers from multidimensional heterogeneous imaging genetics data 
via sparse multimodal multitask learning. Bioinformatics. 2012; 28:i127–i136. [PubMed: 
22689752] 
Wang PJ, Saykin AJ, Flashman LA, Wishart HA, Rabin LA, Santulli RB, McHugh TL, MacDonald 
JW, Mamourian AC. Regionally specific atrophy of the corpus callosum in AD, MCI and cognitive 
complaints. Neurobiology of aging. 2006; 27:1613–1617. [PubMed: 16271806] 
Wang Y, Nie J, Yap PT, Li G, Shi F, Geng X, Guo L, Shen D, Initiative ADN, et al. Knowledge-guided 
robust mri brain extraction for diverse large-scale neuroimaging studies on humans and non-
human primates. PloS one. 2014; 9:e77810. [PubMed: 24489639] 
Wang, Y.; Nie, J.; Yap, PT.; Shi, F.; Guo, L.; Shen, D. Medical Image Computing and Computer-
Assisted Intervention–MICCAI 2011. Springer; 2011. Robust deformable-surface-based skull-
stripping for large-scale studies; p. 635-642.
Wechsler D. A standardized memory scale for clinical use. The Journal of Psychology. 1945; 19:87–
95.
Wee CY, Yap PT, Denny K, Browndyke JN, Potter GG, Welsh-Bohmer KA, Wang L, Shen D. Resting-
state multi-spectrum functional connectivity networks for identification of mci patients. PLOS 
ONE. 2012a; 7:e37828. [PubMed: 22666397] 
Thung et al. Page 16
Brain Struct Funct. Author manuscript; available in PMC 2017 November 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Wee CY, Yap PT, Li W, Denny K, Browndyke JN, Potter GG, Welsh-Bohmer KA, Wang L, Shen D. 
Enriched white matter connectivity networks for accurate identification of MCI patients. Neuro 
Image. 2011; 54:1812–1822. [PubMed: 20970508] 
Wee CY, Yap PT, Shen D. Prediction of alzheimer’s disease and mild cognitive impairment using 
cortical morphological change patterns. Human Brain Mapping. 2013; 34:3411–3425. [PubMed: 
22927119] 
Wee CY, Yap PT, Wang L, Shen D. Group-constrained sparse fmri connectivity modeling for mild 
cognitive impairment identification. Brain Structure and Function. 2014; 219:641–656. [PubMed: 
23468090] 
Wee CY, Yap PT, Zhang D, Denny K, Browndyke JN, Potter GG, Welsh-Bohmer KA, Wang L, Shen 
D. Identification of MCI individuals using structural and functional connectivity networks. Neuro 
Image. 2012b; 59:2045–2056. [PubMed: 22019883] 
Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR, Jagust W, 
Liu E, et al. The Alzheimer’s disease neuroimaging initiative: A review of papers published since 
its inception. Alzheimer’s & Dementia. 2013; 9:e111–e194.
Whitwell JL, Shiung MM, Przybelski S, Weigand SD, Knopman DS, Boeve BF, Petersen RC, Jack 
CR. MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive 
impairment. Neurology. 2008; 70:512–520. [PubMed: 17898323] 
Yonelinas A, Hopfinger J, Buonocore M, Kroll N, Baynes K. Hippocampal, parahippocampal and 
occipital-temporal contributions to associative and item recognition memory: an fMRI study. 
Neuroreport. 2001; 12:359–363. [PubMed: 11209950] 
Zhang, D.; Liu, J.; Shen, D. Medical Image Computing and Computer-Assisted Intervention–MICCAI 
2012. Springer; 2012. Temporally-constrained group sparse learning for longitudinal data analysis; 
p. 264-271.
Zhang D, Shen D. Multi-modal multi-task learning for joint prediction of multiple regression and 
classification variables in Alzheimer’s disease. Neuroimage. 2012a; 59:895–907. [PubMed: 
21992749] 
Zhang D, Shen D. Predicting future clinical changes of MCI patients using longitudinal and 
multimodal biomarkers. PloS one. 2012b; 7:e33182. [PubMed: 22457741] 
Zhang Y, Brady M, Smith S. Segmentation of brain MR images through a hidden Markov random field 
model and the expectation-maximization algorithm. IEEE Transactions on Medical Imaging. 2001; 
20:45–57. [PubMed: 11293691] 
Zhou, J.; Liu, J.; Narayan, VA.; Ye, J. Proceedings of the 18th ACM SIGKDD international conference 
on Knowledge discovery and data mining. ACM; 2012. Modeling disease progression via fused 
sparse group lasso; p. 1095-1103.
Zhou L, Wang Y, Li Y, Yap PT, Shen D, et al. Hierarchical anatomical brain networks for MCI 
prediction: revisiting volumetric measures. PloS one. 2011; 6:e21935. [PubMed: 21818280] 
Zhu, X.; Suk, HI.; Zhu, Y.; Thung, KH.; Wu, G.; Shen, D. Machine Learning in Medical Imaging. 
Springer; 2015. Multi-view classification for identification of Alzheimers disease; p. 255-262.
Zou H, Hastie T. Regularization and variable selection via the elastic net. Journal of the Royal 
Statistical Society: Series B (Statistical Methodology). 2005; 67:301–320.
Thung et al. Page 17
Brain Struct Funct. Author manuscript; available in PMC 2017 November 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 1. 
Overview of the proposed pMCI/sMCI classification framework.
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Figure 2. 
Three ways of handling incomplete data: (a) One subset of complete samples, (b) One 
complete subset for each feature submatrix, and (c) One complete subset for each 
combination of feature submatrices.
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Figure 3. 
Three examples of feature combination: FT, FTD, and FT4D, using data from 2 time points, 
T4 and T3.
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Figure 4. 
Average accuracy (over 10 repetitions of 10-fold cross-validation) of pMCI identification 
using MR data with increasing number of time points. The error bars show the standard 
deviations. The line plots show the changing trend of the proposed mkSVM method with 
increasing time points.
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Figure 5. 
Average AUC of pMCI identification using MR data with increasing number of time points.
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Figure 6. 
Average accuracy of pMCI identification using MR data from two time points of increasing 
scan time interval.
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Figure 7. 
Average AUC of pMCI identification using MR data from two time points of increasing scan 
time interval.
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Figure 8. 
Frequencies of features selected using the proposed feature selection method and FT data, 
under different combinations of time points.
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Figure 9. 
Frequencies of features selected using the proposed feature selection method and FT4D data, 
under different combinations of time points.
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Figure 10. 
Probability density function (pdf) of volumetric differences.
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Table 1
Demographic information of pMCI/sMCI subjects. (Edu.: Education, SD: standard deviation)
Number of subjects Gender Age (years) Edu. (years)
male/female mean ± SD mean ± SD
pMCI 60 36/24 75.2 ± 6.1 15.2 ± 3.4
sMCI 53 30/23 75.7 ± 5.8 15.9 ± 3.2
Total 113 66/47 75.4 ± 5.9 15.5 ± 3.3
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